InvestorsHub Logo
Followers 11
Posts 579
Boards Moderated 0
Alias Born 08/18/2017

Re: None

Thursday, 09/10/2020 7:16:28 PM

Thursday, September 10, 2020 7:16:28 PM

Post# of 718582
Instead of providing a 9/12 update on what they have not done, how about something like this to give us something new to chew on for a couple of weeks?


"While the company remains blinded as we continue to work toward announcing trial results, I wanted to provide this update on the blinded results that we put together…

… regarding our long tail, here is a 2020 update on the KM-derived mOS figures for the top 100 in our 2020 look compared to the 2017 and 2018 interim results…

…to the 2017 and 2018 survival milestones for the entire intent to treat population we’ve not only added the 2020 figures, but we’ve also expanded the analysis to include 4-year and 5-year milestones...

The 2017 and 2018 results were previously reported at the SNO conference in 2018 by Principal Investigator Dr. Linda Liau, and we are pleased that Dr. Liau will again be presenting on this trial at the SNO conference in two months..."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News